• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

BU researcher receives NIH award to examine repetitive head injuries in former NFL players

Bioengineer by Bioengineer
July 19, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(Boston)–Michael Alosco, PhD, assistant professor of neurology at Boston University School of Medicine (BUSM), has received a five-year, $793,000 K23 Award from the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS).

Alosco will use MRI data and biomarkers to examine patterns of white matter alterations in former NFL players compared to healthy individuals, as well as those with Alzheimer's disease dementia. He will do so by leveraging ongoing studies at BUSM, including the NINDS-funded DIAGNOSE CTE Research Project, led by Robert Stern, PhD, professor of neurology, and the National Institute on Aging (NIA) funded BU Alzheimer's Disease Center (BU ADC).

Repetitive brain trauma has been associated with later-life neurological disorders, including the neurodegenerative disease chronic traumatic encephalopathy (CTE). To date, the only way to diagnosis CTE is through brain autopsy. Alosco's research will attempt to provide a better understanding of the development of CTE prior to autopsy. The K23 Award will additionally provide him with advanced and cutting-edge training in CTE to facilitate his progression as an independent clinical neuroscientist.

"This research will allow our group to investigate the relationship between exposure to repetitive head impacts and white matter alterations in former NFL players, as well as investigate the association between white matter alterations with later-life clinical function and proposed biomarkers of CTE," he explained.

Alosco completed his pre-doctoral internship in clinical neuropsychology at the VA Boston Healthcare System. In 2015, he was awarded a post-doctoral fellowship at the BU ADC and BU CTE Center through the NIA-funded Alzheimer's Disease Translational Research Training Program. In 2016, Alosco received a National Research Service Award from NINDS to continue his advanced clinical research training at the BU ADC and BU CTE Center.

Alosco was the recipient of the American Psychological Association Early Graduate Student Research Award in 2012. He received the Kent State University David B. Smith Award in 2014, an award that provides recognition for the most outstanding graduate student at Kent State University. He also received a 2016-2017 BU ADC Pilot Grant. He has authored more than 100 peer-reviewed publications and book chapters, and is the co-editor of the forthcoming Oxford Handbook of Adult Cognitive Disorders. He is a member of the American Psychological Association and Massachusetts Neuropsychological Society.

The K23 Award is a highly competitive grant, formally known as the Mentored Patient-Oriented Research Career Development Award. Its purpose is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

###

Media Contact

Gillian Smith
[email protected]
617-638-8484
@BUMedicine

http://www.bmc.org

Share12Tweet7Share2ShareShareShare1

Related Posts

Phages Modify Cytosine via Hydroxylation and Arabinofuranosylation

April 1, 2026

New Aurodox Compound from Streptomyces Shows Antibacterial Promise

April 1, 2026

AI Model Predicts Depression Risk in Elderly China

April 1, 2026

ASH Releases New Clinical Practice Guidelines for Diagnosing and Managing Severe Acquired Aplastic Anemia

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Correcting Clock and Bmal1’s Role in Cancer Cells

Phages Modify Cytosine via Hydroxylation and Arabinofuranosylation

New Aurodox Compound from Streptomyces Shows Antibacterial Promise

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.